NCPA Calls for Community Pharmacists to Attend Congressional Fly-In

Pharmacists urged to meet with lawmakers and staff to push for PBM reform efforts.

Published on Feb. 24, 2026

The National Community Pharmacists Association (NCPA) is inviting community pharmacists to attend its upcoming Congressional Pharmacy Fly-In on April 15-16 in Washington, D.C. and Alexandria, Virginia. The event aims to give pharmacists the opportunity to meet with members of Congress and their staff to advocate for continued PBM reform and address other issues impacting community pharmacies, such as practices in government programs like Medicaid, Tricare, and the Federal Employee Health Benefit Program.

Why it matters

Recent legislative wins and the FTC settlement with Express Scripts have highlighted the need for ongoing efforts to rein in PBM malfeasance. Community pharmacists play a crucial role in keeping these issues at the forefront of public discourse and pressing lawmakers to take action.

The details

The NCPA Congressional Pharmacy Fly-In will allow community pharmacists to directly engage with their representatives in Congress and their staff to advocate for PBM reform and other regulatory priorities. Attendees will receive guidance and support from NCPA to make the most of these face-to-face meetings, which can have a significant impact on shaping the legislative agenda.

  • The Congressional Pharmacy Fly-In is scheduled for April 15-16, 2026.
  • Registration for the event is open now, but slots are expected to fill up quickly.

The players

National Community Pharmacists Association (NCPA)

A national trade association representing the interests of community pharmacists and independent pharmacy owners across the United States.

Got photos? Submit your photos here. ›

What’s next

Community pharmacists interested in attending the fly-in are encouraged to register as soon as possible, as spaces are limited.

The takeaway

By participating in the NCPA Congressional Pharmacy Fly-In, community pharmacists can play a direct role in advocating for critical reforms to address PBM practices and other issues impacting their businesses and patients.